The strategy begins with medications, followed by balloon pulmonary angioplasty, and pulmonary endarterectomy surgery, a ...

Experimental treatment ALG-801 was shown to be more effective than approved PAH therapies at reducing signs of disease in an animal model.

Worldwide, pulmonary arterial hypertension affects more than 2 of every 100,000 women and girls of childbearing age, a new ...

A pulmonary hypertension diagnosis left columnist Jolie Lizana with more grief than she could handle. Now she believes she's ...

The upcoming video events will discuss the importance of shared decision making between doctors and patients in managing PH ...

Winrevair, when added to standard of care, reduced clinical worsening events by 76% in adults recently diagnosed with PAH, ...

Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, ...

Gossamer Bio is moving toward acquiring Respira Therapeutics and its lead treatment candidate, RT234, an inhaled therapy being developed for the on-demand treatment of pulmonary hypertension (PH). The ...

Underweight infants with pulmonary hypertension (PH) are at increased risk of developing retinopathy of prematurity (ROP), a leading cause of childhood blindness, according to a study. However, the ...

Allrock Bio has raised $50 million in financing to support the clinical development of pulmonary hypertension (PH) treatment ROC-101. The company said it will use the funds to launch a Phase 2a ...